nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethoprim—TYMS—prostate cancer	0.253	0.767	CbGaD
Trimethoprim—TYMS—Capecitabine—prostate cancer	0.107	0.238	CbGbCtD
Trimethoprim—CYP3A4—prostate cancer	0.0771	0.233	CbGaD
Trimethoprim—CYP2C8—Nilutamide—prostate cancer	0.0267	0.0596	CbGbCtD
Trimethoprim—CYP2C8—Abiraterone—prostate cancer	0.0221	0.0494	CbGbCtD
Trimethoprim—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0206	0.046	CbGbCtD
Trimethoprim—CYP2C9—Nilutamide—prostate cancer	0.0186	0.0415	CbGbCtD
Trimethoprim—CYP2C9—Bicalutamide—prostate cancer	0.0186	0.0415	CbGbCtD
Trimethoprim—ABCB1—Estramustine—prostate cancer	0.0168	0.0375	CbGbCtD
Trimethoprim—CYP2C8—Cabazitaxel—prostate cancer	0.0163	0.0365	CbGbCtD
Trimethoprim—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0142	0.0318	CbGbCtD
Trimethoprim—CYP2C9—Estrone—prostate cancer	0.0111	0.0249	CbGbCtD
Trimethoprim—ABCB1—Cabazitaxel—prostate cancer	0.0111	0.0247	CbGbCtD
Trimethoprim—CYP3A4—Bicalutamide—prostate cancer	0.0108	0.0242	CbGbCtD
Trimethoprim—ABCB1—Estrone—prostate cancer	0.0108	0.0242	CbGbCtD
Trimethoprim—CYP3A4—Estramustine—prostate cancer	0.0101	0.0225	CbGbCtD
Trimethoprim—ABCB1—Ethinyl Estradiol—prostate cancer	0.00963	0.0215	CbGbCtD
Trimethoprim—CYP2C8—Estradiol—prostate cancer	0.00917	0.0205	CbGbCtD
Trimethoprim—CYP3A4—Abiraterone—prostate cancer	0.00896	0.02	CbGbCtD
Trimethoprim—CYP3A4—Flutamide—prostate cancer	0.00896	0.02	CbGbCtD
Trimethoprim—CYP2C9—Capecitabine—prostate cancer	0.00844	0.0189	CbGbCtD
Trimethoprim—ABCB1—Conjugated Estrogens—prostate cancer	0.00707	0.0158	CbGbCtD
Trimethoprim—CYP3A4—Cabazitaxel—prostate cancer	0.00663	0.0148	CbGbCtD
Trimethoprim—CYP3A4—Estrone—prostate cancer	0.00648	0.0145	CbGbCtD
Trimethoprim—ABCB1—Mitoxantrone—prostate cancer	0.00643	0.0144	CbGbCtD
Trimethoprim—CYP2C9—Estradiol—prostate cancer	0.0064	0.0143	CbGbCtD
Trimethoprim—ABCB1—Estradiol—prostate cancer	0.00621	0.0139	CbGbCtD
Trimethoprim—CYP2C8—Etoposide—prostate cancer	0.00599	0.0134	CbGbCtD
Trimethoprim—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00577	0.0129	CbGbCtD
Trimethoprim—ABCB1—Prednisone—prostate cancer	0.00534	0.0119	CbGbCtD
Trimethoprim—CYP3A4—Conjugated Estrogens—prostate cancer	0.00424	0.00947	CbGbCtD
Trimethoprim—ABCB1—Etoposide—prostate cancer	0.00405	0.00906	CbGbCtD
Trimethoprim—CYP3A4—Mitoxantrone—prostate cancer	0.00385	0.00861	CbGbCtD
Trimethoprim—CYP3A4—Estradiol—prostate cancer	0.00372	0.00831	CbGbCtD
Trimethoprim—ABCB1—Docetaxel—prostate cancer	0.00371	0.00829	CbGbCtD
Trimethoprim—CYP3A4—Prednisone—prostate cancer	0.0032	0.00715	CbGbCtD
Trimethoprim—ABCB1—Doxorubicin—prostate cancer	0.00276	0.00618	CbGbCtD
Trimethoprim—CYP3A4—Etoposide—prostate cancer	0.00243	0.00543	CbGbCtD
Trimethoprim—CYP3A4—Docetaxel—prostate cancer	0.00222	0.00497	CbGbCtD
Trimethoprim—CYP2C9—urine—prostate cancer	0.00174	0.112	CbGeAlD
Trimethoprim—CYP3A4—Doxorubicin—prostate cancer	0.00166	0.0037	CbGbCtD
Trimethoprim—TYMS—prostate gland—prostate cancer	0.00143	0.0921	CbGeAlD
Trimethoprim—DHFR—prostate gland—prostate cancer	0.00142	0.0912	CbGeAlD
Trimethoprim—CYP3A4—urine—prostate cancer	0.00133	0.0854	CbGeAlD
Trimethoprim—DHFR—seminal vesicle—prostate cancer	0.0012	0.0772	CbGeAlD
Trimethoprim—TYMS—Docetaxel—Cabazitaxel—prostate cancer	0.000985	0.349	CbGdCrCtD
Trimethoprim—DHFR—renal system—prostate cancer	0.000966	0.0622	CbGeAlD
Trimethoprim—DHFR—urethra—prostate cancer	0.000949	0.0611	CbGeAlD
Trimethoprim—TYMS—bone marrow—prostate cancer	0.000738	0.0475	CbGeAlD
Trimethoprim—DHFR—bone marrow—prostate cancer	0.00073	0.047	CbGeAlD
Trimethoprim—TYMS—Paclitaxel—Cabazitaxel—prostate cancer	0.00068	0.241	CbGdCrCtD
Trimethoprim—TYMS—testis—prostate cancer	0.000631	0.0406	CbGeAlD
Trimethoprim—DHFR—testis—prostate cancer	0.000624	0.0402	CbGeAlD
Trimethoprim—CYP2C8—renal system—prostate cancer	0.00048	0.0309	CbGeAlD
Trimethoprim—TYMS—lymph node—prostate cancer	0.000457	0.0294	CbGeAlD
Trimethoprim—DHFR—lymph node—prostate cancer	0.000453	0.0291	CbGeAlD
Trimethoprim—ABCB1—prostate gland—prostate cancer	0.000337	0.0217	CbGeAlD
Trimethoprim—CYP3A4—renal system—prostate cancer	0.000325	0.0209	CbGeAlD
Trimethoprim—CYP2C8—testis—prostate cancer	0.00031	0.02	CbGeAlD
Trimethoprim—ABCB1—seminal vesicle—prostate cancer	0.000285	0.0184	CbGeAlD
Trimethoprim—TYMS—Paclitaxel—Docetaxel—prostate cancer	0.000282	0.1	CbGdCrCtD
Trimethoprim—ABCB1—epithelium—prostate cancer	0.000248	0.016	CbGeAlD
Trimethoprim—ABCB1—renal system—prostate cancer	0.00023	0.0148	CbGeAlD
Trimethoprim—ABCB1—urethra—prostate cancer	0.000226	0.0145	CbGeAlD
Trimethoprim—TYMS—Podofilox—Etoposide—prostate cancer	0.000181	0.0642	CbGdCrCtD
Trimethoprim—TYMS—Levorphanol—Estrone—prostate cancer	0.00018	0.0636	CbGdCrCtD
Trimethoprim—ABCB1—bone marrow—prostate cancer	0.000174	0.0112	CbGeAlD
Trimethoprim—ABCB1—testis—prostate cancer	0.000149	0.00957	CbGeAlD
Trimethoprim—TYMS—Levorphanol—Estradiol—prostate cancer	0.000136	0.0482	CbGdCrCtD
Trimethoprim—ABCB1—lymph node—prostate cancer	0.000108	0.00693	CbGeAlD
Trimethoprim—TYMS—Danazol—Ethinyl Estradiol—prostate cancer	9e-05	0.0318	CbGdCrCtD
Trimethoprim—TYMS—Levonorgestrel—Ethinyl Estradiol—prostate cancer	6.45e-05	0.0228	CbGdCrCtD
Trimethoprim—Erythema—Prednisone—prostate cancer	5.84e-05	0.000499	CcSEcCtD
Trimethoprim—Malnutrition—Prednisone—prostate cancer	5.84e-05	0.000499	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Epirubicin—prostate cancer	5.8e-05	0.000495	CcSEcCtD
Trimethoprim—Decreased appetite—Etoposide—prostate cancer	5.78e-05	0.000494	CcSEcCtD
Trimethoprim—Myalgia—Docetaxel—prostate cancer	5.77e-05	0.000493	CcSEcCtD
Trimethoprim—Arthralgia—Docetaxel—prostate cancer	5.77e-05	0.000493	CcSEcCtD
Trimethoprim—Loss of consciousness—Capecitabine—prostate cancer	5.76e-05	0.000492	CcSEcCtD
Trimethoprim—Pancytopenia—Doxorubicin—prostate cancer	5.76e-05	0.000492	CcSEcCtD
Trimethoprim—Renal failure—Epirubicin—prostate cancer	5.75e-05	0.000491	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Etoposide—prostate cancer	5.74e-05	0.000491	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Epirubicin—prostate cancer	5.73e-05	0.00049	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	5.73e-05	0.000489	CcSEcCtD
Trimethoprim—Cough—Capecitabine—prostate cancer	5.72e-05	0.000489	CcSEcCtD
Trimethoprim—Stomatitis—Epirubicin—prostate cancer	5.7e-05	0.000487	CcSEcCtD
Trimethoprim—Constipation—Etoposide—prostate cancer	5.69e-05	0.000486	CcSEcCtD
Trimethoprim—Dizziness—Estradiol—prostate cancer	5.67e-05	0.000485	CcSEcCtD
Trimethoprim—Neutropenia—Doxorubicin—prostate cancer	5.67e-05	0.000485	CcSEcCtD
Trimethoprim—Arthralgia—Capecitabine—prostate cancer	5.58e-05	0.000477	CcSEcCtD
Trimethoprim—Myalgia—Capecitabine—prostate cancer	5.58e-05	0.000477	CcSEcCtD
Trimethoprim—Haematuria—Epirubicin—prostate cancer	5.57e-05	0.000476	CcSEcCtD
Trimethoprim—Confusional state—Docetaxel—prostate cancer	5.57e-05	0.000476	CcSEcCtD
Trimethoprim—Anxiety—Capecitabine—prostate cancer	5.56e-05	0.000475	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	5.54e-05	0.000474	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Doxorubicin—prostate cancer	5.54e-05	0.000473	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Epirubicin—prostate cancer	5.53e-05	0.000472	CcSEcCtD
Trimethoprim—Anaphylactic shock—Docetaxel—prostate cancer	5.53e-05	0.000472	CcSEcCtD
Trimethoprim—Epistaxis—Epirubicin—prostate cancer	5.51e-05	0.000471	CcSEcCtD
Trimethoprim—Feeling abnormal—Etoposide—prostate cancer	5.48e-05	0.000468	CcSEcCtD
Trimethoprim—Diarrhoea—Mitoxantrone—prostate cancer	5.47e-05	0.000467	CcSEcCtD
Trimethoprim—Vomiting—Estradiol—prostate cancer	5.46e-05	0.000466	CcSEcCtD
Trimethoprim—Agranulocytosis—Epirubicin—prostate cancer	5.45e-05	0.000466	CcSEcCtD
Trimethoprim—Pneumonia—Doxorubicin—prostate cancer	5.44e-05	0.000465	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Etoposide—prostate cancer	5.44e-05	0.000465	CcSEcCtD
Trimethoprim—Shock—Docetaxel—prostate cancer	5.44e-05	0.000465	CcSEcCtD
Trimethoprim—Nervous system disorder—Docetaxel—prostate cancer	5.42e-05	0.000463	CcSEcCtD
Trimethoprim—Thrombocytopenia—Docetaxel—prostate cancer	5.41e-05	0.000462	CcSEcCtD
Trimethoprim—Rash—Estradiol—prostate cancer	5.41e-05	0.000462	CcSEcCtD
Trimethoprim—Infestation NOS—Doxorubicin—prostate cancer	5.41e-05	0.000462	CcSEcCtD
Trimethoprim—Infestation—Doxorubicin—prostate cancer	5.41e-05	0.000462	CcSEcCtD
Trimethoprim—Dermatitis—Estradiol—prostate cancer	5.41e-05	0.000462	CcSEcCtD
Trimethoprim—Confusional state—Capecitabine—prostate cancer	5.4e-05	0.000461	CcSEcCtD
Trimethoprim—Headache—Estradiol—prostate cancer	5.38e-05	0.000459	CcSEcCtD
Trimethoprim—Skin disorder—Docetaxel—prostate cancer	5.37e-05	0.000459	CcSEcCtD
Trimethoprim—Agitation—Prednisone—prostate cancer	5.37e-05	0.000459	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	5.36e-05	0.000458	CcSEcCtD
Trimethoprim—Angioedema—Prednisone—prostate cancer	5.34e-05	0.000456	CcSEcCtD
Trimethoprim—Renal failure—Doxorubicin—prostate cancer	5.32e-05	0.000454	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Doxorubicin—prostate cancer	5.3e-05	0.000453	CcSEcCtD
Trimethoprim—Urticaria—Etoposide—prostate cancer	5.28e-05	0.000451	CcSEcCtD
Trimethoprim—Stomatitis—Doxorubicin—prostate cancer	5.27e-05	0.00045	CcSEcCtD
Trimethoprim—Anorexia—Docetaxel—prostate cancer	5.27e-05	0.00045	CcSEcCtD
Trimethoprim—Shock—Capecitabine—prostate cancer	5.26e-05	0.00045	CcSEcCtD
Trimethoprim—Abdominal pain—Etoposide—prostate cancer	5.26e-05	0.000449	CcSEcCtD
Trimethoprim—Body temperature increased—Etoposide—prostate cancer	5.26e-05	0.000449	CcSEcCtD
Trimethoprim—Nervous system disorder—Capecitabine—prostate cancer	5.25e-05	0.000448	CcSEcCtD
Trimethoprim—Vertigo—Prednisone—prostate cancer	5.25e-05	0.000448	CcSEcCtD
Trimethoprim—Thrombocytopenia—Capecitabine—prostate cancer	5.24e-05	0.000448	CcSEcCtD
Trimethoprim—Syncope—Prednisone—prostate cancer	5.24e-05	0.000448	CcSEcCtD
Trimethoprim—Skin disorder—Capecitabine—prostate cancer	5.2e-05	0.000444	CcSEcCtD
Trimethoprim—Urinary tract disorder—Epirubicin—prostate cancer	5.18e-05	0.000443	CcSEcCtD
Trimethoprim—Haematuria—Doxorubicin—prostate cancer	5.16e-05	0.000441	CcSEcCtD
Trimethoprim—Connective tissue disorder—Epirubicin—prostate cancer	5.16e-05	0.000441	CcSEcCtD
Trimethoprim—Urethral disorder—Epirubicin—prostate cancer	5.14e-05	0.00044	CcSEcCtD
Trimethoprim—Loss of consciousness—Prednisone—prostate cancer	5.13e-05	0.000439	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Doxorubicin—prostate cancer	5.12e-05	0.000437	CcSEcCtD
Trimethoprim—Epistaxis—Doxorubicin—prostate cancer	5.1e-05	0.000436	CcSEcCtD
Trimethoprim—Anorexia—Capecitabine—prostate cancer	5.1e-05	0.000436	CcSEcCtD
Trimethoprim—Nausea—Estradiol—prostate cancer	5.1e-05	0.000436	CcSEcCtD
Trimethoprim—Vomiting—Mitoxantrone—prostate cancer	5.08e-05	0.000434	CcSEcCtD
Trimethoprim—Convulsion—Prednisone—prostate cancer	5.06e-05	0.000432	CcSEcCtD
Trimethoprim—Agranulocytosis—Doxorubicin—prostate cancer	5.05e-05	0.000431	CcSEcCtD
Trimethoprim—Rash—Mitoxantrone—prostate cancer	5.04e-05	0.000431	CcSEcCtD
Trimethoprim—Dermatitis—Mitoxantrone—prostate cancer	5.04e-05	0.00043	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Docetaxel—prostate cancer	5.04e-05	0.00043	CcSEcCtD
Trimethoprim—Headache—Mitoxantrone—prostate cancer	5.01e-05	0.000428	CcSEcCtD
Trimethoprim—Insomnia—Docetaxel—prostate cancer	5e-05	0.000427	CcSEcCtD
Trimethoprim—Myalgia—Prednisone—prostate cancer	4.97e-05	0.000425	CcSEcCtD
Trimethoprim—Arthralgia—Prednisone—prostate cancer	4.97e-05	0.000425	CcSEcCtD
Trimethoprim—Erythema multiforme—Epirubicin—prostate cancer	4.96e-05	0.000424	CcSEcCtD
Trimethoprim—Anxiety—Prednisone—prostate cancer	4.96e-05	0.000423	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	4.94e-05	0.000422	CcSEcCtD
Trimethoprim—Dyspnoea—Docetaxel—prostate cancer	4.93e-05	0.000421	CcSEcCtD
Trimethoprim—Eye disorder—Epirubicin—prostate cancer	4.9e-05	0.000419	CcSEcCtD
Trimethoprim—Hypersensitivity—Etoposide—prostate cancer	4.9e-05	0.000419	CcSEcCtD
Trimethoprim—Tinnitus—Epirubicin—prostate cancer	4.89e-05	0.000418	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Capecitabine—prostate cancer	4.88e-05	0.000417	CcSEcCtD
Trimethoprim—Dyspepsia—Docetaxel—prostate cancer	4.87e-05	0.000416	CcSEcCtD
Trimethoprim—Insomnia—Capecitabine—prostate cancer	4.84e-05	0.000414	CcSEcCtD
Trimethoprim—Decreased appetite—Docetaxel—prostate cancer	4.8e-05	0.000411	CcSEcCtD
Trimethoprim—Urinary tract disorder—Doxorubicin—prostate cancer	4.79e-05	0.00041	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Docetaxel—prostate cancer	4.77e-05	0.000408	CcSEcCtD
Trimethoprim—Connective tissue disorder—Doxorubicin—prostate cancer	4.77e-05	0.000408	CcSEcCtD
Trimethoprim—Dyspnoea—Capecitabine—prostate cancer	4.77e-05	0.000408	CcSEcCtD
Trimethoprim—Anaphylactic shock—Prednisone—prostate cancer	4.77e-05	0.000407	CcSEcCtD
Trimethoprim—Urethral disorder—Doxorubicin—prostate cancer	4.76e-05	0.000407	CcSEcCtD
Trimethoprim—Nausea—Mitoxantrone—prostate cancer	4.75e-05	0.000406	CcSEcCtD
Trimethoprim—Immune system disorder—Epirubicin—prostate cancer	4.74e-05	0.000405	CcSEcCtD
Trimethoprim—Mediastinal disorder—Epirubicin—prostate cancer	4.73e-05	0.000404	CcSEcCtD
Trimethoprim—Constipation—Docetaxel—prostate cancer	4.73e-05	0.000404	CcSEcCtD
Trimethoprim—Dyspepsia—Capecitabine—prostate cancer	4.71e-05	0.000403	CcSEcCtD
Trimethoprim—Pruritus—Etoposide—prostate cancer	4.71e-05	0.000402	CcSEcCtD
Trimethoprim—Shock—Prednisone—prostate cancer	4.69e-05	0.000401	CcSEcCtD
Trimethoprim—Nervous system disorder—Prednisone—prostate cancer	4.67e-05	0.000399	CcSEcCtD
Trimethoprim—Decreased appetite—Capecitabine—prostate cancer	4.65e-05	0.000397	CcSEcCtD
Trimethoprim—Skin disorder—Prednisone—prostate cancer	4.63e-05	0.000396	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Capecitabine—prostate cancer	4.62e-05	0.000395	CcSEcCtD
Trimethoprim—Mental disorder—Epirubicin—prostate cancer	4.6e-05	0.000393	CcSEcCtD
Trimethoprim—Erythema multiforme—Doxorubicin—prostate cancer	4.59e-05	0.000392	CcSEcCtD
Trimethoprim—Constipation—Capecitabine—prostate cancer	4.58e-05	0.000391	CcSEcCtD
Trimethoprim—Malnutrition—Epirubicin—prostate cancer	4.57e-05	0.00039	CcSEcCtD
Trimethoprim—Erythema—Epirubicin—prostate cancer	4.57e-05	0.00039	CcSEcCtD
Trimethoprim—Feeling abnormal—Docetaxel—prostate cancer	4.55e-05	0.000389	CcSEcCtD
Trimethoprim—Diarrhoea—Etoposide—prostate cancer	4.55e-05	0.000389	CcSEcCtD
Trimethoprim—Anorexia—Prednisone—prostate cancer	4.54e-05	0.000388	CcSEcCtD
Trimethoprim—Eye disorder—Doxorubicin—prostate cancer	4.54e-05	0.000388	CcSEcCtD
Trimethoprim—Tinnitus—Doxorubicin—prostate cancer	4.53e-05	0.000387	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Docetaxel—prostate cancer	4.52e-05	0.000386	CcSEcCtD
Trimethoprim—Feeling abnormal—Capecitabine—prostate cancer	4.41e-05	0.000377	CcSEcCtD
Trimethoprim—Dizziness—Etoposide—prostate cancer	4.4e-05	0.000376	CcSEcCtD
Trimethoprim—Immune system disorder—Doxorubicin—prostate cancer	4.39e-05	0.000375	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Capecitabine—prostate cancer	4.38e-05	0.000374	CcSEcCtD
Trimethoprim—Mediastinal disorder—Doxorubicin—prostate cancer	4.38e-05	0.000374	CcSEcCtD
Trimethoprim—Abdominal pain—Docetaxel—prostate cancer	4.37e-05	0.000373	CcSEcCtD
Trimethoprim—Body temperature increased—Docetaxel—prostate cancer	4.37e-05	0.000373	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Prednisone—prostate cancer	4.34e-05	0.000371	CcSEcCtD
Trimethoprim—Insomnia—Prednisone—prostate cancer	4.31e-05	0.000368	CcSEcCtD
Trimethoprim—Mental disorder—Doxorubicin—prostate cancer	4.25e-05	0.000363	CcSEcCtD
Trimethoprim—Urticaria—Capecitabine—prostate cancer	4.25e-05	0.000363	CcSEcCtD
Trimethoprim—Abdominal pain—Capecitabine—prostate cancer	4.23e-05	0.000361	CcSEcCtD
Trimethoprim—Body temperature increased—Capecitabine—prostate cancer	4.23e-05	0.000361	CcSEcCtD
Trimethoprim—Vomiting—Etoposide—prostate cancer	4.23e-05	0.000361	CcSEcCtD
Trimethoprim—Erythema—Doxorubicin—prostate cancer	4.23e-05	0.000361	CcSEcCtD
Trimethoprim—Malnutrition—Doxorubicin—prostate cancer	4.23e-05	0.000361	CcSEcCtD
Trimethoprim—Agitation—Epirubicin—prostate cancer	4.2e-05	0.000359	CcSEcCtD
Trimethoprim—Dyspepsia—Prednisone—prostate cancer	4.2e-05	0.000359	CcSEcCtD
Trimethoprim—Rash—Etoposide—prostate cancer	4.19e-05	0.000358	CcSEcCtD
Trimethoprim—Dermatitis—Etoposide—prostate cancer	4.19e-05	0.000358	CcSEcCtD
Trimethoprim—TYMS—Clobetasol propionate—Prednisone—prostate cancer	4.18e-05	0.0148	CbGdCrCtD
Trimethoprim—Headache—Etoposide—prostate cancer	4.17e-05	0.000356	CcSEcCtD
Trimethoprim—Decreased appetite—Prednisone—prostate cancer	4.14e-05	0.000354	CcSEcCtD
Trimethoprim—TYMS—Flunisolide—Prednisone—prostate cancer	4.12e-05	0.0146	CbGdCrCtD
Trimethoprim—Vertigo—Epirubicin—prostate cancer	4.1e-05	0.000351	CcSEcCtD
Trimethoprim—Syncope—Epirubicin—prostate cancer	4.1e-05	0.00035	CcSEcCtD
Trimethoprim—Leukopenia—Epirubicin—prostate cancer	4.09e-05	0.000349	CcSEcCtD
Trimethoprim—TYMS—Triamcinolone—Prednisone—prostate cancer	4.08e-05	0.0144	CbGdCrCtD
Trimethoprim—Constipation—Prednisone—prostate cancer	4.08e-05	0.000348	CcSEcCtD
Trimethoprim—Hypersensitivity—Docetaxel—prostate cancer	4.07e-05	0.000348	CcSEcCtD
Trimethoprim—Loss of consciousness—Epirubicin—prostate cancer	4.01e-05	0.000343	CcSEcCtD
Trimethoprim—Cough—Epirubicin—prostate cancer	3.99e-05	0.000341	CcSEcCtD
Trimethoprim—Convulsion—Epirubicin—prostate cancer	3.96e-05	0.000338	CcSEcCtD
Trimethoprim—Nausea—Etoposide—prostate cancer	3.95e-05	0.000338	CcSEcCtD
Trimethoprim—Hypersensitivity—Capecitabine—prostate cancer	3.94e-05	0.000337	CcSEcCtD
Trimethoprim—Feeling abnormal—Prednisone—prostate cancer	3.93e-05	0.000336	CcSEcCtD
Trimethoprim—Pruritus—Docetaxel—prostate cancer	3.91e-05	0.000334	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Prednisone—prostate cancer	3.9e-05	0.000333	CcSEcCtD
Trimethoprim—Myalgia—Epirubicin—prostate cancer	3.89e-05	0.000332	CcSEcCtD
Trimethoprim—Arthralgia—Epirubicin—prostate cancer	3.89e-05	0.000332	CcSEcCtD
Trimethoprim—Agitation—Doxorubicin—prostate cancer	3.88e-05	0.000332	CcSEcCtD
Trimethoprim—Anxiety—Epirubicin—prostate cancer	3.88e-05	0.000331	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	3.86e-05	0.00033	CcSEcCtD
Trimethoprim—Vertigo—Doxorubicin—prostate cancer	3.8e-05	0.000324	CcSEcCtD
Trimethoprim—Syncope—Doxorubicin—prostate cancer	3.79e-05	0.000324	CcSEcCtD
Trimethoprim—Urticaria—Prednisone—prostate cancer	3.79e-05	0.000324	CcSEcCtD
Trimethoprim—Pruritus—Capecitabine—prostate cancer	3.79e-05	0.000324	CcSEcCtD
Trimethoprim—Leukopenia—Doxorubicin—prostate cancer	3.78e-05	0.000323	CcSEcCtD
Trimethoprim—Diarrhoea—Docetaxel—prostate cancer	3.78e-05	0.000323	CcSEcCtD
Trimethoprim—Abdominal pain—Prednisone—prostate cancer	3.77e-05	0.000322	CcSEcCtD
Trimethoprim—Body temperature increased—Prednisone—prostate cancer	3.77e-05	0.000322	CcSEcCtD
Trimethoprim—TYMS—Diflorasone—Prednisone—prostate cancer	3.76e-05	0.0133	CbGdCrCtD
Trimethoprim—Confusional state—Epirubicin—prostate cancer	3.76e-05	0.000321	CcSEcCtD
Trimethoprim—Anaphylactic shock—Epirubicin—prostate cancer	3.73e-05	0.000319	CcSEcCtD
Trimethoprim—Loss of consciousness—Doxorubicin—prostate cancer	3.71e-05	0.000317	CcSEcCtD
Trimethoprim—Cough—Doxorubicin—prostate cancer	3.69e-05	0.000315	CcSEcCtD
Trimethoprim—Shock—Epirubicin—prostate cancer	3.67e-05	0.000313	CcSEcCtD
Trimethoprim—Convulsion—Doxorubicin—prostate cancer	3.66e-05	0.000313	CcSEcCtD
Trimethoprim—Diarrhoea—Capecitabine—prostate cancer	3.66e-05	0.000313	CcSEcCtD
Trimethoprim—Nervous system disorder—Epirubicin—prostate cancer	3.66e-05	0.000312	CcSEcCtD
Trimethoprim—Dizziness—Docetaxel—prostate cancer	3.66e-05	0.000312	CcSEcCtD
Trimethoprim—Thrombocytopenia—Epirubicin—prostate cancer	3.65e-05	0.000312	CcSEcCtD
Trimethoprim—Skin disorder—Epirubicin—prostate cancer	3.62e-05	0.000309	CcSEcCtD
Trimethoprim—Myalgia—Doxorubicin—prostate cancer	3.6e-05	0.000307	CcSEcCtD
Trimethoprim—Arthralgia—Doxorubicin—prostate cancer	3.6e-05	0.000307	CcSEcCtD
Trimethoprim—Anxiety—Doxorubicin—prostate cancer	3.59e-05	0.000306	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	3.57e-05	0.000305	CcSEcCtD
Trimethoprim—Anorexia—Epirubicin—prostate cancer	3.55e-05	0.000304	CcSEcCtD
Trimethoprim—Dizziness—Capecitabine—prostate cancer	3.54e-05	0.000302	CcSEcCtD
Trimethoprim—Vomiting—Docetaxel—prostate cancer	3.51e-05	0.0003	CcSEcCtD
Trimethoprim—Hypersensitivity—Prednisone—prostate cancer	3.51e-05	0.0003	CcSEcCtD
Trimethoprim—Rash—Docetaxel—prostate cancer	3.49e-05	0.000298	CcSEcCtD
Trimethoprim—Dermatitis—Docetaxel—prostate cancer	3.48e-05	0.000298	CcSEcCtD
Trimethoprim—Confusional state—Doxorubicin—prostate cancer	3.48e-05	0.000297	CcSEcCtD
Trimethoprim—Headache—Docetaxel—prostate cancer	3.46e-05	0.000296	CcSEcCtD
Trimethoprim—Anaphylactic shock—Doxorubicin—prostate cancer	3.45e-05	0.000295	CcSEcCtD
Trimethoprim—Vomiting—Capecitabine—prostate cancer	3.4e-05	0.000291	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Epirubicin—prostate cancer	3.4e-05	0.00029	CcSEcCtD
Trimethoprim—Shock—Doxorubicin—prostate cancer	3.39e-05	0.00029	CcSEcCtD
Trimethoprim—Nervous system disorder—Doxorubicin—prostate cancer	3.38e-05	0.000289	CcSEcCtD
Trimethoprim—Thrombocytopenia—Doxorubicin—prostate cancer	3.38e-05	0.000289	CcSEcCtD
Trimethoprim—Rash—Capecitabine—prostate cancer	3.37e-05	0.000288	CcSEcCtD
Trimethoprim—Pruritus—Prednisone—prostate cancer	3.37e-05	0.000288	CcSEcCtD
Trimethoprim—Insomnia—Epirubicin—prostate cancer	3.37e-05	0.000288	CcSEcCtD
Trimethoprim—Dermatitis—Capecitabine—prostate cancer	3.37e-05	0.000288	CcSEcCtD
Trimethoprim—Headache—Capecitabine—prostate cancer	3.35e-05	0.000286	CcSEcCtD
Trimethoprim—Skin disorder—Doxorubicin—prostate cancer	3.35e-05	0.000286	CcSEcCtD
Trimethoprim—Dyspnoea—Epirubicin—prostate cancer	3.32e-05	0.000284	CcSEcCtD
Trimethoprim—TYMS—Budesonide—Prednisone—prostate cancer	3.3e-05	0.0117	CbGdCrCtD
Trimethoprim—Anorexia—Doxorubicin—prostate cancer	3.29e-05	0.000281	CcSEcCtD
Trimethoprim—Nausea—Docetaxel—prostate cancer	3.28e-05	0.000281	CcSEcCtD
Trimethoprim—Dyspepsia—Epirubicin—prostate cancer	3.28e-05	0.00028	CcSEcCtD
Trimethoprim—Diarrhoea—Prednisone—prostate cancer	3.26e-05	0.000279	CcSEcCtD
Trimethoprim—Decreased appetite—Epirubicin—prostate cancer	3.24e-05	0.000277	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Epirubicin—prostate cancer	3.22e-05	0.000275	CcSEcCtD
Trimethoprim—Constipation—Epirubicin—prostate cancer	3.19e-05	0.000272	CcSEcCtD
Trimethoprim—Nausea—Capecitabine—prostate cancer	3.18e-05	0.000272	CcSEcCtD
Trimethoprim—TYMS—Danazol—Prednisone—prostate cancer	3.16e-05	0.0112	CbGdCrCtD
Trimethoprim—Dizziness—Prednisone—prostate cancer	3.15e-05	0.000269	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Doxorubicin—prostate cancer	3.14e-05	0.000269	CcSEcCtD
Trimethoprim—Insomnia—Doxorubicin—prostate cancer	3.12e-05	0.000267	CcSEcCtD
Trimethoprim—Dyspnoea—Doxorubicin—prostate cancer	3.08e-05	0.000263	CcSEcCtD
Trimethoprim—Feeling abnormal—Epirubicin—prostate cancer	3.07e-05	0.000263	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Epirubicin—prostate cancer	3.05e-05	0.00026	CcSEcCtD
Trimethoprim—Dyspepsia—Doxorubicin—prostate cancer	3.04e-05	0.000259	CcSEcCtD
Trimethoprim—Vomiting—Prednisone—prostate cancer	3.03e-05	0.000259	CcSEcCtD
Trimethoprim—Rash—Prednisone—prostate cancer	3.01e-05	0.000257	CcSEcCtD
Trimethoprim—Dermatitis—Prednisone—prostate cancer	3e-05	0.000257	CcSEcCtD
Trimethoprim—Decreased appetite—Doxorubicin—prostate cancer	3e-05	0.000256	CcSEcCtD
Trimethoprim—Headache—Prednisone—prostate cancer	2.99e-05	0.000255	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.98e-05	0.000254	CcSEcCtD
Trimethoprim—Urticaria—Epirubicin—prostate cancer	2.96e-05	0.000253	CcSEcCtD
Trimethoprim—Constipation—Doxorubicin—prostate cancer	2.95e-05	0.000252	CcSEcCtD
Trimethoprim—Abdominal pain—Epirubicin—prostate cancer	2.95e-05	0.000252	CcSEcCtD
Trimethoprim—Body temperature increased—Epirubicin—prostate cancer	2.95e-05	0.000252	CcSEcCtD
Trimethoprim—Feeling abnormal—Doxorubicin—prostate cancer	2.84e-05	0.000243	CcSEcCtD
Trimethoprim—Nausea—Prednisone—prostate cancer	2.83e-05	0.000242	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Doxorubicin—prostate cancer	2.82e-05	0.000241	CcSEcCtD
Trimethoprim—Hypersensitivity—Epirubicin—prostate cancer	2.75e-05	0.000235	CcSEcCtD
Trimethoprim—Urticaria—Doxorubicin—prostate cancer	2.74e-05	0.000234	CcSEcCtD
Trimethoprim—Abdominal pain—Doxorubicin—prostate cancer	2.73e-05	0.000233	CcSEcCtD
Trimethoprim—Body temperature increased—Doxorubicin—prostate cancer	2.73e-05	0.000233	CcSEcCtD
Trimethoprim—Pruritus—Epirubicin—prostate cancer	2.64e-05	0.000225	CcSEcCtD
Trimethoprim—Diarrhoea—Epirubicin—prostate cancer	2.55e-05	0.000218	CcSEcCtD
Trimethoprim—Hypersensitivity—Doxorubicin—prostate cancer	2.54e-05	0.000217	CcSEcCtD
Trimethoprim—Dizziness—Epirubicin—prostate cancer	2.47e-05	0.000211	CcSEcCtD
Trimethoprim—Pruritus—Doxorubicin—prostate cancer	2.44e-05	0.000209	CcSEcCtD
Trimethoprim—Vomiting—Epirubicin—prostate cancer	2.37e-05	0.000203	CcSEcCtD
Trimethoprim—Diarrhoea—Doxorubicin—prostate cancer	2.36e-05	0.000202	CcSEcCtD
Trimethoprim—Rash—Epirubicin—prostate cancer	2.35e-05	0.000201	CcSEcCtD
Trimethoprim—Dermatitis—Epirubicin—prostate cancer	2.35e-05	0.000201	CcSEcCtD
Trimethoprim—Headache—Epirubicin—prostate cancer	2.34e-05	0.0002	CcSEcCtD
Trimethoprim—Dizziness—Doxorubicin—prostate cancer	2.28e-05	0.000195	CcSEcCtD
Trimethoprim—Nausea—Epirubicin—prostate cancer	2.21e-05	0.000189	CcSEcCtD
Trimethoprim—Vomiting—Doxorubicin—prostate cancer	2.19e-05	0.000187	CcSEcCtD
Trimethoprim—Rash—Doxorubicin—prostate cancer	2.17e-05	0.000186	CcSEcCtD
Trimethoprim—Dermatitis—Doxorubicin—prostate cancer	2.17e-05	0.000186	CcSEcCtD
Trimethoprim—Headache—Doxorubicin—prostate cancer	2.16e-05	0.000185	CcSEcCtD
Trimethoprim—Nausea—Doxorubicin—prostate cancer	2.05e-05	0.000175	CcSEcCtD
Trimethoprim—ABCB1—Metabolism—SLC22A1—prostate cancer	4.89e-06	5.65e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—PPARA—prostate cancer	4.88e-06	5.64e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP2C19—prostate cancer	4.87e-06	5.63e-05	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PIK3CB—prostate cancer	4.87e-06	5.62e-05	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PTGS2—prostate cancer	4.82e-06	5.57e-05	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PTEN—prostate cancer	4.82e-06	5.57e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—TNFRSF21—prostate cancer	4.8e-06	5.55e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	4.8e-06	5.55e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PLCB2—prostate cancer	4.78e-06	5.53e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP2C18—prostate cancer	4.78e-06	5.53e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—LRP2—prostate cancer	4.78e-06	5.53e-05	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MYC—prostate cancer	4.78e-06	5.53e-05	CbGpPWpGaD
Trimethoprim—DHFR—Disease—TGFB1—prostate cancer	4.77e-06	5.51e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—SULT2A1—prostate cancer	4.76e-06	5.5e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	4.76e-06	5.5e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GSTT1—prostate cancer	4.75e-06	5.49e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ACHE—prostate cancer	4.75e-06	5.49e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP2A6—prostate cancer	4.7e-06	5.43e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—P4HB—prostate cancer	4.69e-06	5.42e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—MED12—prostate cancer	4.68e-06	5.41e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	4.68e-06	5.41e-05	CbGpPWpGaD
Trimethoprim—DHFR—Disease—EGFR—prostate cancer	4.68e-06	5.4e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP7B1—prostate cancer	4.67e-06	5.4e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—MTAP—prostate cancer	4.67e-06	5.4e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GNG5—prostate cancer	4.65e-06	5.37e-05	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—EP300—prostate cancer	4.59e-06	5.31e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—AKR1C3—prostate cancer	4.57e-06	5.28e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—SLC22A1—prostate cancer	4.56e-06	5.28e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SRD5A1—prostate cancer	4.55e-06	5.26e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SULT1E1—prostate cancer	4.55e-06	5.26e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PRKACB—prostate cancer	4.55e-06	5.26e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	4.51e-06	5.21e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP17A1—prostate cancer	4.5e-06	5.2e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—NCOA3—prostate cancer	4.48e-06	5.17e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—SULT2A1—prostate cancer	4.45e-06	5.14e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	4.44e-06	5.13e-05	CbGpPWpGaD
Trimethoprim—DHFR—Disease—KRAS—prostate cancer	4.42e-06	5.11e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—MED12—prostate cancer	4.38e-06	5.06e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ACSL4—prostate cancer	4.34e-06	5.02e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—HSD17B3—prostate cancer	4.34e-06	5.02e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GNG5—prostate cancer	4.34e-06	5.02e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—NCOA2—prostate cancer	4.29e-06	4.96e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—HPGDS—prostate cancer	4.27e-06	4.94e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP2C19—prostate cancer	4.24e-06	4.9e-05	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PTEN—prostate cancer	4.2e-06	4.86e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—NCOA3—prostate cancer	4.18e-06	4.83e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ARG2—prostate cancer	4.16e-06	4.81e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PHGDH—prostate cancer	4.16e-06	4.81e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—UMPS—prostate cancer	4.16e-06	4.81e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GSTT1—prostate cancer	4.14e-06	4.79e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ACHE—prostate cancer	4.14e-06	4.79e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	4.11e-06	4.75e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP2A6—prostate cancer	4.09e-06	4.73e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—SLC5A5—prostate cancer	4.09e-06	4.73e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—LDHB—prostate cancer	4.08e-06	4.72e-05	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PIK3CA—prostate cancer	4.06e-06	4.69e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	4.02e-06	4.65e-05	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—EP300—prostate cancer	4.01e-06	4.63e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP3A5—prostate cancer	4.01e-06	4.63e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP2E1—prostate cancer	4e-06	4.62e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—HPGDS—prostate cancer	3.99e-06	4.61e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—AKR1C3—prostate cancer	3.98e-06	4.6e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP2C19—prostate cancer	3.96e-06	4.58e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PRKACB—prostate cancer	3.96e-06	4.58e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—NQO1—prostate cancer	3.95e-06	4.57e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP17A1—prostate cancer	3.92e-06	4.53e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—TH—prostate cancer	3.89e-06	4.5e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	3.88e-06	4.48e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GSTA3—prostate cancer	3.87e-06	4.47e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—TCN2—prostate cancer	3.87e-06	4.47e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—UCP3—prostate cancer	3.87e-06	4.47e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PDHA1—prostate cancer	3.87e-06	4.47e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GSTT1—prostate cancer	3.87e-06	4.47e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ACHE—prostate cancer	3.87e-06	4.47e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.87e-06	4.47e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP3A4—prostate cancer	3.85e-06	4.45e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.83e-06	4.43e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP2A6—prostate cancer	3.82e-06	4.42e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.81e-06	4.4e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP1B1—prostate cancer	3.79e-06	4.38e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—NCOA2—prostate cancer	3.74e-06	4.32e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—AKR1C3—prostate cancer	3.72e-06	4.3e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PRKACB—prostate cancer	3.7e-06	4.28e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SLC22A3—prostate cancer	3.69e-06	4.27e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—HSD3B1—prostate cancer	3.69e-06	4.27e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GGT1—prostate cancer	3.67e-06	4.24e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP17A1—prostate cancer	3.66e-06	4.23e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—NCOA1—prostate cancer	3.61e-06	4.18e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.61e-06	4.18e-05	CbGpPWpGaD
Trimethoprim—DHFR—Disease—IL6—prostate cancer	3.59e-06	4.15e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—SLC5A5—prostate cancer	3.56e-06	4.12e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP19A1—prostate cancer	3.56e-06	4.12e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—TBXAS1—prostate cancer	3.54e-06	4.09e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GSTA4—prostate cancer	3.54e-06	4.09e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—NCOA2—prostate cancer	3.49e-06	4.03e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP2E1—prostate cancer	3.48e-06	4.02e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GSTA2—prostate cancer	3.45e-06	3.99e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—NQO1—prostate cancer	3.44e-06	3.98e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—RXRA—prostate cancer	3.44e-06	3.97e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ABCG5—prostate cancer	3.41e-06	3.94e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SULT1A1—prostate cancer	3.41e-06	3.94e-05	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PIK3CA—prostate cancer	3.4e-06	3.93e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—TH—prostate cancer	3.39e-06	3.92e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP3A4—prostate cancer	3.36e-06	3.88e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.34e-06	3.86e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—SLC5A5—prostate cancer	3.33e-06	3.85e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GSTA1—prostate cancer	3.33e-06	3.85e-05	CbGpPWpGaD
Trimethoprim—DHFR—Disease—AKT1—prostate cancer	3.32e-06	3.83e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—COMT—prostate cancer	3.31e-06	3.83e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP1B1—prostate cancer	3.3e-06	3.81e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GSTP1—prostate cancer	3.3e-06	3.81e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GSTO1—prostate cancer	3.29e-06	3.8e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—NAT2—prostate cancer	3.29e-06	3.8e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—HSD3B2—prostate cancer	3.29e-06	3.8e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP2E1—prostate cancer	3.25e-06	3.76e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ITPR1—prostate cancer	3.24e-06	3.75e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—NQO1—prostate cancer	3.22e-06	3.72e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GGT1—prostate cancer	3.2e-06	3.69e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.19e-06	3.69e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—TH—prostate cancer	3.17e-06	3.66e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PLCB2—prostate cancer	3.16e-06	3.65e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—LRP2—prostate cancer	3.16e-06	3.65e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP2C18—prostate cancer	3.16e-06	3.65e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.15e-06	3.64e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—NCOA1—prostate cancer	3.15e-06	3.64e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP3A4—prostate cancer	3.14e-06	3.62e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.12e-06	3.61e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP19A1—prostate cancer	3.1e-06	3.59e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—P4HB—prostate cancer	3.09e-06	3.58e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP1B1—prostate cancer	3.08e-06	3.56e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—TYMS—prostate cancer	3.06e-06	3.54e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GSTM1—prostate cancer	3.03e-06	3.5e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SLC22A1—prostate cancer	3.01e-06	3.48e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—RXRA—prostate cancer	2.99e-06	3.46e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GGT1—prostate cancer	2.99e-06	3.45e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—LPL—prostate cancer	2.97e-06	3.44e-05	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PIK3CA—prostate cancer	2.97e-06	3.43e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—NCOA1—prostate cancer	2.94e-06	3.4e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.93e-06	3.39e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP19A1—prostate cancer	2.9e-06	3.35e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—MED12—prostate cancer	2.89e-06	3.34e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—COMT—prostate cancer	2.88e-06	3.33e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GSTP1—prostate cancer	2.87e-06	3.32e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP1A1—prostate cancer	2.87e-06	3.32e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GNG5—prostate cancer	2.86e-06	3.31e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ERCC2—prostate cancer	2.85e-06	3.29e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ITPR1—prostate cancer	2.83e-06	3.27e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—RXRA—prostate cancer	2.8e-06	3.23e-05	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—AKT1—prostate cancer	2.78e-06	3.21e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—NCOA3—prostate cancer	2.76e-06	3.19e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.72e-06	3.14e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—COMT—prostate cancer	2.69e-06	3.11e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GSTP1—prostate cancer	2.68e-06	3.1e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—MTHFR—prostate cancer	2.68e-06	3.09e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—TYMS—prostate cancer	2.67e-06	3.08e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ITPR1—prostate cancer	2.64e-06	3.05e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GSTM1—prostate cancer	2.64e-06	3.05e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—HPGDS—prostate cancer	2.63e-06	3.04e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PPARA—prostate cancer	2.63e-06	3.03e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.61e-06	3.02e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.6e-06	3e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—LPL—prostate cancer	2.59e-06	2.99e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GSTT1—prostate cancer	2.55e-06	2.95e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ACHE—prostate cancer	2.55e-06	2.95e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.52e-06	2.92e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP1A1—prostate cancer	2.5e-06	2.89e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—TYMS—prostate cancer	2.49e-06	2.88e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ERCC2—prostate cancer	2.48e-06	2.87e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CAV1—prostate cancer	2.47e-06	2.85e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GSTM1—prostate cancer	2.46e-06	2.85e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.45e-06	2.84e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PRKACB—prostate cancer	2.44e-06	2.82e-05	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—AKT1—prostate cancer	2.42e-06	2.8e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—LPL—prostate cancer	2.42e-06	2.8e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.42e-06	2.79e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.36e-06	2.73e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP1A1—prostate cancer	2.34e-06	2.7e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—MTHFR—prostate cancer	2.33e-06	2.69e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ERCC2—prostate cancer	2.32e-06	2.68e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—NCOA2—prostate cancer	2.3e-06	2.66e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PPARA—prostate cancer	2.29e-06	2.64e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CG—prostate cancer	2.25e-06	2.6e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.2e-06	2.54e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—MTHFR—prostate cancer	2.18e-06	2.52e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CAV1—prostate cancer	2.15e-06	2.49e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.14e-06	2.48e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PPARA—prostate cancer	2.14e-06	2.47e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—INS—prostate cancer	2.13e-06	2.46e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—NQO1—prostate cancer	2.12e-06	2.45e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—TH—prostate cancer	2.09e-06	2.42e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CREBBP—prostate cancer	2.08e-06	2.41e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP1B1—prostate cancer	2.03e-06	2.35e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CAV1—prostate cancer	2.01e-06	2.32e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CD—prostate cancer	1.98e-06	2.28e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GGT1—prostate cancer	1.97e-06	2.28e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CG—prostate cancer	1.96e-06	2.26e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—NCOA1—prostate cancer	1.94e-06	2.24e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.92e-06	2.22e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.91e-06	2.21e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—NOS3—prostate cancer	1.87e-06	2.16e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—INS—prostate cancer	1.85e-06	2.14e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—RXRA—prostate cancer	1.85e-06	2.13e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.83e-06	2.12e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CREBBP—prostate cancer	1.82e-06	2.1e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—COMT—prostate cancer	1.78e-06	2.05e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GSTP1—prostate cancer	1.77e-06	2.04e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ITPR1—prostate cancer	1.74e-06	2.01e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—INS—prostate cancer	1.73e-06	2e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CB—prostate cancer	1.72e-06	1.99e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CD—prostate cancer	1.72e-06	1.99e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PTGS2—prostate cancer	1.71e-06	1.97e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CREBBP—prostate cancer	1.7e-06	1.96e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—TYMS—prostate cancer	1.64e-06	1.9e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—NOS3—prostate cancer	1.63e-06	1.88e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GSTM1—prostate cancer	1.63e-06	1.88e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.61e-06	1.86e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—LPL—prostate cancer	1.6e-06	1.84e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.54e-06	1.78e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ERCC2—prostate cancer	1.53e-06	1.77e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—NOS3—prostate cancer	1.52e-06	1.76e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CB—prostate cancer	1.5e-06	1.73e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PTEN—prostate cancer	1.49e-06	1.72e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PTGS2—prostate cancer	1.49e-06	1.72e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—MTHFR—prostate cancer	1.44e-06	1.66e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—EP300—prostate cancer	1.42e-06	1.64e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PPARA—prostate cancer	1.41e-06	1.63e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.4e-06	1.62e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PTGS2—prostate cancer	1.39e-06	1.61e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CAV1—prostate cancer	1.33e-06	1.53e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PTEN—prostate cancer	1.3e-06	1.5e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—EP300—prostate cancer	1.24e-06	1.43e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PTEN—prostate cancer	1.21e-06	1.4e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.21e-06	1.39e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—EP300—prostate cancer	1.16e-06	1.34e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—INS—prostate cancer	1.14e-06	1.32e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CREBBP—prostate cancer	1.12e-06	1.29e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.06e-06	1.23e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CA—prostate cancer	1.05e-06	1.21e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—NOS3—prostate cancer	1e-06	1.16e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CB—prostate cancer	9.25e-07	1.07e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PTGS2—prostate cancer	9.16e-07	1.06e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CA—prostate cancer	9.15e-07	1.06e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—AKT1—prostate cancer	8.58e-07	9.92e-06	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CA—prostate cancer	8.55e-07	9.88e-06	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PTEN—prostate cancer	7.99e-07	9.24e-06	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—EP300—prostate cancer	7.62e-07	8.81e-06	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—AKT1—prostate cancer	7.48e-07	8.64e-06	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—AKT1—prostate cancer	6.98e-07	8.07e-06	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CA—prostate cancer	5.64e-07	6.52e-06	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—AKT1—prostate cancer	4.61e-07	5.32e-06	CbGpPWpGaD
